Health
EU Greenlights First Targeted COPD Therapy, Dupixent
Sanofi and Regeneron have received European Union approval for their Dupixent injection for the treatment of chronic obstructive pulmonary disease (COPD), a condition primarily affecting cigarette smokers. This approval marks a rare instance of the EU clearing a drug faster than the United States, where the U.S. Food and